Reports
Reports
Sale
The global aesthetic fillers market size was valued at USD 5.49 billion in 2023. The major drivers of the market include the high disposable income, growing acceptance of tissue fillers, increasing investment in aesthetic filler treatment, rising research and development activities, increasing trend of using anti-ageing treatments. The market is anticipated to grow at a CAGR of 7.6% during the forecast period 2024-2032 to reach a value of USD 10.61 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The overall aesthetic filler industry is dominated by North America, with the United States accounting for the largest share. Lately, consumers worldwide have been showing increasing interest in their aesthetic appearance, and this is due to the rising availability of necessary infrastructure and skilled professionals in the region. Also, government and companies' increased funding available for research and development activities supports the North American market. The growing demand for aesthetic filler devices, availability of advanced products, and rising interest of the market player in aesthetic appearance are further driving the market growth in the region. Increasing product availability, high disposable income, and rising approvals by the United States FDA will broaden product accessibility. Furthermore, increasing population spending on aesthetic procedures will fortify the regional growth during the forecast period.
The Asia Pacific region is likely to rise at a high rate during the forecast period. The growth can be attributed to the growing investment by market players, emerging economies, increasing demand for advanced technology for facial associated treatment, a large number of cosmetic procedures, and rising awareness amongst the population about the usage of products and non-surgical aesthetic filler procedures.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Aesthetic fillers are gel-like substances injected into the skin to restore lost volume, smooth lines, soften wrinkles, along with improving facial contours. The common aesthetic filler procedures are non-surgical procedures that use hyaluronic acid, collagen, polymers, and particles to give the skin a youthful appearance. Many material types, such as polymer and particles, collagen, and hyaluronic acid, are increasingly introduced in the aesthetic filler market.
By product type, the market includes:
Based on material type, the aesthetic fillers industry is segmented into:
The major applications of the market are:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The regional markets for the aesthetic fillers industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The factors that aid the growth of the global aesthetic fillers industry include the increasing demand for the ever-expanding range of dermal fillers and non-surgical aesthetic procedures, growing acceptance of tissue fillers with rising dermal filler surgeries, rising attention on facial aesthetics amongst the older population, a growing number of operations performed, growing demand for facial aesthetics, increasing investment in aesthetic filler treatment, such as dermal filler injections, new eco-friendly products, and rising research and development activities. The key players' recent launch of new products is projected to grow the market.
For instance, in October 2018, Allergan-AbbVie launched an injectable dermal filler called JUVEDERM®, which is used as an anti-ageing injectable. The growth of the global market can also be attributed to the increasing trend of using anti-ageing treatments and the demand for a much younger lifestyle. Additionally, product development providing high patient satisfaction will positively impact the product demand during the forecast timeframe. Also, the expanding network of healthcare facilities, such as clinics, medical spas, and rejuvenation centres providing advanced aesthetic treatments with improving infrastructure, will support the aesthetic filler industry during the forecast period.
The report gives a detailed analysis of the following key players in the global aesthetic fillers market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Material Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Aesthetic Fillers Market Overview
3.1 Aesthetic Fillers Market Historical Value (2017-2023)
3.2 Aesthetic Fillers Market Forecast Value (2024-2032)
4 Global Aesthetic Fillers Market Landscape
4.1 Aesthetic Fillers: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Aesthetic Fillers: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End user
5 Global Aesthetic Fillers Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Aesthetic Fillers Market Segmentation
6.1 Aesthetic Fillers Market by Type
6.1.1 Market Overview
6.1.2 Absorbable
6.1.3 Non-absorbable
6.2 Aesthetic Fillers Market by Material Type
6.2.1 Market Overview
6.2.2 Polymers and Particles
6.2.3 Collagen
6.2.4 Hyaluronic Acid
6.3 Aesthetic Fillers Market by Application
6.3.1 Market Overview
6.3.2 Facial Line Correction
6.3.3 Face Lift
6.3.4 Lip Treatment
6.3.5 Other Applications
6.4 Aesthetic Fillers Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Beauty Clinics
6.4.4 Others
6.5 Aesthetic Fillers Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Aesthetic Fillers
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Aesthetic Fillers
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Aesthetic Fillers
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Aesthetic Fillers
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Aesthetic Fillers
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 AbbVie Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BioPlus Co. Ltd.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bioxis Pharmaceuticals
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Galderma Pharma SA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Laboratoires Vivacy SAS
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Merz Pharma
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 SCULPT Dermal Fillers Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Sinclair Pharma
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Suneva Medical Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Teoxane
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Aesthetic Fillers - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global aesthetic fillers market reached a value of USD 5.49 billion in 2023.
The market is projected to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to reach a value of USD 10.61 billion by 2032.
The major drivers of the market include the high disposable income, growing acceptance of tissue fillers with rising dermal filler surgeries, increasing investment in aesthetic filler treatment, rising research and development activities, increasing trend of using anti-ageing treatments and expanding network of healthcare facilities.
Increasing demand for the expanding range of dermal fillers and non-surgical aesthetic procedures and the growing demand for facial aesthetics are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on product type, the market is segmented into absorbable and non-absorbable.
The different types of materials are polymers and particles, collagen, and hyaluronic acid.
The major applications of the market are facial line correction, facelift, and lip treatment, among others.
The major players in the industry are AbbVie Inc., Galderma S.A., Vital Esthetique, Merz Pharma GmbH & Co.KGaA, Sinclair Pharma PLC, and Teoxane SA, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.